HURLY STEPHEN A 4
4 · Eleven Biotherapeutics, Inc. · Filed Mar 16, 2018
Insider Transaction Report
Form 4
HURLY STEPHEN A
DirectorPresident and CEO
Transactions
- Award
Common Stock
2018-03-14+105,000→ 105,000 totalExercise: $1.59From: 2018-03-14Exp: 2027-10-03→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]On October 4, 2017, the reporting person was granted an option to purchase 420,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On March 14, 2018, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 105,000 shares.